Head To Head Top Stocks: Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Zillow Group, Inc. (NASDAQ:ZG)

u.s stocks , earnings estimates

Sarepta Therapeutics, Inc. (NASDAQ:SRPT)

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) closed at $129.41 on the last trading session with an decrease of -2.41%, whereas, it previously closed at $132.6. The company has a market capitalization of $9.45 Billion. The company traded shares of 1.21 Million on the trading day while its three month average volume stands at 1.31 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) produced diluted EPS of -5.42. The EPS estimate for next year as estimated by analysts is at -2.47 while EPS for next quarter is estimated at -1.64. Earnings per Share growth for this year is reported at -533.9, while the analysts estimated the EPS growth for next year at -2.47% and Earnings growth for next 5 years stands at -0.2% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -10.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands at 31.39 and Price to Book or P/B for the most recent quarter stands at 8.6. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) are reported at 7.5 and 8.2 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands at -26.9, -46 and -23.6 respectively

The trailing twelve month Revenue of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is reported at 301 Million with income of -361900000. The outstanding shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) are 73 Million. The institutional Ownership of the shares of 95.7 stands at 0.80%, this figure is increased 11.14 in the last six months. The insider ownership for the shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is ticked at 0.8%, the figure is plummeted -32.6% in the last six months.

Some other important financial aspects to be discussed here for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is the Mean Target Price estimated by the analysts which stands at 201.67. The 52 week high of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is placed at 176.50 and 52 week low is standing at 70.50.

Performance wise the shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) fell down -3.37% for the week, it also fell -2.63% for the monthly performance, while for the quarter it went down 3.53%. The shares decrease -9.81% for the half year and flew up for the Year-To-Date performance. The shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT) grew 59.96% for the yearly performance.

Zillow Group, Inc. (NASDAQ:ZG)

Zillow Group, Inc. (NASDAQ:ZG) closed at $37.61 on the last trading session with an decrease of -3.39%, whereas, it previously closed at $38.93. The company has a market capitalization of $7.61 Billion. The company traded shares of 719906 on the trading day while its three month average volume stands at 877.02 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Zillow Group, Inc. (NASDAQ:ZG) produced diluted EPS of -0.59. The EPS estimate for next year as estimated by analysts is at -0.28 while EPS for next quarter is estimated at -0.18. Earnings per Share growth for this year is reported at 4.3, while the analysts estimated the EPS growth for next year at -0.28% and Earnings growth for next 5 years stands at 5% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -11.9%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Zillow Group, Inc. (NASDAQ:ZG) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Zillow Group, Inc. (NASDAQ:ZG) stands at 5.7 and Price to Book or P/B for the most recent quarter stands at 2.37. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Zillow Group, Inc. (NASDAQ:ZG) are reported at 6 and 6.6 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Zillow Group, Inc. (NASDAQ:ZG) stands at -3.1, -3.9 and -2.4 respectively

The trailing twelve month Revenue of Zillow Group, Inc. (NASDAQ:ZG) is reported at 1.33 Billion with income of -119900000. The outstanding shares of Zillow Group, Inc. (NASDAQ:ZG) are 202.26 Million. The institutional Ownership of the shares of 91.6 stands at 0.80%, this figure is increased 1.07 in the last six months. The insider ownership for the shares of Zillow Group, Inc. (NASDAQ:ZG) is ticked at 0.8%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Zillow Group, Inc. (NASDAQ:ZG) is the Mean Target Price estimated by the analysts which stands at 37.5. The 52 week high of Zillow Group, Inc. (NASDAQ:ZG) is placed at 65.42 and 52 week low is standing at 26.20.

Performance wise the shares of Zillow Group, Inc. (NASDAQ:ZG) rose up 1.32% for the week, it also rise 5.03% for the monthly performance, while for the quarter it went down 5.71%. The shares decrease -19.55% for the half year and flew up for the Year-To-Date performance. The shares of Zillow Group, Inc. (NASDAQ:ZG) shrinked -34.19% for the yearly performance.